SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898432-08-001076
Filing Date
2008-10-23
Accepted
2008-10-23 16:10:03
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 avigen_sc13d.htm SC 13D 256428
  Complete submission text file 0000898432-08-001076.txt   258565
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48313 | Film No.: 081137460
SIC: 2835 In Vitro & In Vivo Diagnostic Substances